Consensus

DOI: 10.4244/EIJ-JAA-202501

Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society

Jean-Claude Deharo1,2; Julien Dreyfus3; Maria-Grazia Bongiorni4; Haran Burri5; Pascal Defaye6; Michael Glikson7; Nigel Lever8; Antonio Mangieri9; Blandine Mondésert10; Jens Cosedis Nielsen11,12; Maully Shah13; Christoph Thomas Starck14; Archana Rao15; Christophe Leclercq16; Fabien Praz17

Abstract

Up to one-third of patients referred for transcatheter tricuspid valve intervention (TTVI) have a transvalvular pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead in place. Both the electrophysiology and interventional cardiology communities have been alerted to the complexity of decision-making in this situation due to potential interactions between the leads and the TTVI material, including the risk of jailing or damage to the leads. This document, commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, reviews the scientific evidence to inform Heart Team discussions on the management of patients with a PPM or ICD who are scheduled for or have undergone TTVI. Graphical abstract.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 22
Nov 14, 2025
Volume 21 Number 22
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00052 Jan 19, 2026
Residual postprocedural gradients after transcatheter aortic valve implantation: a small number with a big impact?
Rheude T and Alvarez Covarrubias H
free

Editorial

10.4244/EIJ-E-25-00054 Jan 19, 2026
Randomised trials in mitral transcatheter edge-to-edge repair: taking yet another look
Besler C and Westermann D
free

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free

Original Research

10.4244/EIJ-D-25-00575 Jan 19, 2026
Predictors of long-term structural valve deterioration and failure after transcatheter aortic valve implantation
Palmerini T et al

Research Correspondence

10.4244/EIJ-D-25-00603 Jan 19, 2026
Atrial fibrillation following patent foramen ovale closure: a cohort study with continuous implantable cardiac monitoring
Gautier P et al
open access

Flashlight

10.4244/EIJ-D-25-00658 Jan 19, 2026
Paraplegia after implantation of a transcatheter aortic valve
Zahn R et al

Letter to the editor

10.4244/EIJ-D-25-00949 Jan 19, 2026
Letter: Beta blocker withdrawal post-MI - the missed dimension of patient symptoms
Shamsulddin A
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved